Skip to main content

Nephropathic Cystinosis

 Nephropathic Cystinosis



Overview

Nephropathic cystinosis, also known as infantile or early-onset cystinosis, is a severe, inherited disorder where cystine, an amino acid, builds up in the body's lysosomes (cellular compartments that break down waste). This buildup primarily affects the kidneys, leading to a condition called Fanconi syndrome, and if left untreated, can progress to end-stage renal disease. It's caused by mutations in the CTNS gene, which is responsible for producing the cystinosis protein, a lysosomal transporter. 

Symptoms

Kidney Dysfunction:

Fanconi Syndrome: The kidneys lose essential substances like sodium, potassium, phosphate, and glucose in the urine, leading to electrolyte imbalances. 

Polyuria and Polydipsia: Excessive urination and thirst due to the kidneys' inability to concentrate urine. 

Dehydration: Can result from fluid loss due to excessive urination. 

Growth Impairment: Children with nephropathic cystinosis often experience failure to thrive and delayed puberty. 

Gastrointestinal Issues: Vomiting, diarrhea, and feeding difficulties can occur due to electrolyte imbalances and kidney dysfunction. 

Muscle Weakness: Muscle weakness and neuromuscular issues can also develop. 

Photophobia: Sensitivity to light due to cystine crystal deposits in the cornea, often developing later in childhood. 

Metabolic Acidosis: Can occur due to the kidneys' inability to regulate acid-base balance. 

Progression of Symptoms:

Infants may present with failure to thrive, polyuria, polydipsia, and electrolyte imbalances.

By ages 3-4, photophobia often develops.

Without treatment, renal failure can occur by ages 10-12.

Neurological symptoms, such as tremor and hypotonia, can also develop. 

Causes

Genetic Basis:

Cystinosis is an autosomal recessive disorder, meaning an individual needs to inherit two copies of the mutated CTNS gene (one from each parent) to develop the condition. 

Cystinosis Deficiency:

The CTNS gene provides instructions for making the cystinosis protein. In cystinosis, mutations in this gene impair cystinosis's ability to transport cystine out of lysosomes. 

Lysosomal Accumulation:

Cystine, an amino acid, accumulates within the lysosomes due to the defective cystinosin. This buildup forms crystals that damage cells and tissues, particularly in the kidneys, eyes, and other organs. 

Organ Damage:

The accumulation of cystine crystals leads to a range of complications, including Fanconi syndrome (a kidney disorder) and eventually end-stage renal disease in nephropathic cystinosis. 

Geographic Variations:

While the phenotype (clinical presentation) of cystinosis is generally the same, different pathogenic mutations in the CTNS gene can be found in various geographic regions. 

Diagnosis

Clinical Evaluation:

A thorough assessment of the patient's medical history, symptoms (including growth impairment, kidney dysfunction, and photophobia), and physical examination is the first step. 

Laboratory Tests:

White Blood Cell Cystine Measurement: Measuring cystine levels in white blood cells is a primary diagnostic test. Elevated levels confirm the presence of cystinosis. 

Urinalysis: Urine tests can detect the excess loss of minerals, nutrients, electrolytes, and amino acids, which are characteristic of Fanconi syndrome, a common complication of nephropathic cystinosis. 

Other blood tests and kidney function tests: These are used to assess the overall health of the kidneys and other organs. 

Genetic Testing:

Analysis of the CTNS gene, which is responsible for cystinosis, can identify specific mutations and confirm the diagnosis. 

Eye Examination:

An ophthalmologist can use a slit lamp to examine the cornea for cystine crystals, which are a hallmark of the disease. 

Kidney Biopsy:

In some cases, a kidney biopsy may be performed to assess the extent of cystine crystal accumulation and tissue damage. 

Prenatal Testing:

If there is a family history of cystinosis, prenatal testing (amniocentesis or chorionic villus sampling) may be offered to assess the risk of the fetus developing the condition. 

Treatment

Cystagon™ (immediate-release) and Procyclin™ (delayed-release):

These are the two forms of cysteamine available. Cystagon™ requires frequent dosing (every 6 hours), while Procyclin™ is a delayed-release version that can be taken every 12 hours, according to Cleveland Clinic. 

Cysteamine Eye Drops:

Cystaran™ and Cyst drops™ are cysteamine eye drops used to dissolve corneal cystine crystals and relieve light sensitivity. 

Goal of Treatment:

Cysteamine therapy aims to lower cystine levels in cells, slowing the progression of kidney damage and improving overall outcomes. Early and consistent treatment is crucial for maximizing its benefits. 

Management of Fanconi Syndrome:

Fluid and Electrolyte Management:

Cystinosis can cause the kidneys to lose essential fluids and electrolytes, requiring careful monitoring and replacement. 

Nutritional Adjustments:

Nutritional support, including supplements and potentially growth hormones, may be needed to address deficiencies caused by Fanconi syndrome. 

Type of Doctor Department :  A nephrologist 


Comments

Popular posts from this blog

Charge Syndrome

Overview CHARGE syndrome is a recognizable genetic syndrome with known pattern of features. It is an extremely complex syndrome, involving extensive medical and physical difficulties that differ from child to child. CHARGE syndrome is correlated with genetic mutation to CHD7 and the prevalence of CHARGE syndrome is 1:10,000-1:15,000 live births. Babies with CHARGE syndrome are often born with life-threatening birth defects. They spend many months in the hospital and undergo many surgeries and other treatments. Swallowing and breathing problems make life difficult even when they come home. Most have hearing two little girls sitting on a carpet, one girl has a trach and is biting her finger.loss, vision loss, and balance problems that delay their development and communication. Despite these seemingly insurmountable obstacles, children with CHARGE syndrome often far surpass their medical, physical, educational, and social expectations. One of the hidden features of CHARGE syndrome is the ...

Acral Peeling Skin Syndrome

Overview Acral peeling skin syndrome is a skin disorder characterized by painless peeling of the top layer of skin. The term "acral" refers to the fact that the skin peeling in this condition is most apparent on the hands and feet. Occasionally, peeling also occurs on the arms and legs. The peeling is usually evident from birth, although the condition can also begin in childhood or later in life. Skin peeling is made worse by exposure to heat, humidity and other forms of moisture, and friction. The underlying skin may be temporarily red and itchy, but it typically heals without scarring. Acral peeling skin syndrome is not associated with any other health problems. Symptoms The main symptom of APSS is the painless peeling of the skin. Most people can remove this skin by hand, and it may come off in sheets, similar to peeling skin after a sunburn. 1. blistering 2. itching 3. easily removable hairs If a person exposes their skin to heat, sweat, or water, they may notice that the...

Sjogren's syndrome

Sjogren's syndrome Overview Sjogren's (SHOW-grins) syndrome is a disorder of your immune system identified by its two most common symptoms — dry eyes and a dry mouth. The condition often accompanies other immune system disorders, such as rheumatoid arthritis and lupus. In Sjogren's syndrome, the mucous membranes and moisture-secreting glands of your eyes and mouth are usually affected first — resulting in decreased tears and saliva. Although you can develop Sjogren's syndrome at any age, most people are older than 40 at the time of diagnosis. The condition is much more common in women. Treatment focuses on relieving symptoms. Symptoms The two main symptoms of Sjogren's syndrome are: Dry eyes . Your eyes might burn, itch or feel gritty — as if there's sand in them. Dry mouth. Your mouth might feel like it's full of cotton, making it difficult to swallow or speak. Some people with Sjogren's syndrome also have one or more of the following: Joint pain, swel...